Methylation in pericytes after acute injury promotes chronic kidney disease

Yu-Hsiang Chou1,2,3, Szu-Yu Pan1,3,4, Yu-Han Shao3

  • 1Renal Division, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Insights

Renal myofibroblasts originate from pericytes after acute kidney injury (AKI). Epigenetic changes in these cells promote chronic kidney disease (CKD) progression, but demethylation therapy can prevent this transition.

Area of Science:

  • Nephrology
  • Cell Biology
  • Epigenetics

Background:

  • The origin and long-term fate of renal myofibroblasts following acute kidney injury (AKI) remain unclear.
  • Pericytes are implicated in kidney repair, but their transformation into myofibroblasts and subsequent role in disease progression require further elucidation.

Purpose of the Study:

  • To investigate the origin and fate of renal myofibroblasts after ischemia/reperfusion injury-induced AKI (IRI-AKI).
  • To explore the epigenetic mechanisms regulating pericyte function and their role in the transition from AKI to chronic kidney disease (CKD).
  • To evaluate the therapeutic potential of demethylation in preventing AKI-CKD transition and mitigating renal fibrosis.

Main Methods:

  • Isolation and gene expression profiling (microarray) of quiescent (qPericytes), activated (aPericytes/myofibroblasts), and inactivated (iPericytes) from kidneys at different time points post-IRI-AKI.
  • Analysis of Acta2 gene regulation, including Ybx2 methylation and transforming growth factor-β1 (TGF-β1) signaling.
  • In vivo administration of 5-azacytidine (a demethylating agent) to assess its effects on renal recovery, fibrosis, and AKI-CKD transition following IRI-AKI and a second AKI.

Main Results:

  • Myofibroblasts are activated from qPericytes post-IRI-AKI, with a subset surviving and proliferating long-term.
  • Hypermethylation of the Acta2 repressor Ybx2 in iPericytes promotes AKI-CKD transition and exacerbates fibrogenesis.
  • TGF-β1 induces Ybx2 hypermethylation, increasing α-smooth muscle actin expression in aPericytes.
  • 5-azacytidine treatment restored microvascular function, reversed profibrotic properties, prevented AKI-CKD transition, and attenuated fibrosis after a second AKI.

Conclusions:

  • Pericyte epigenetic dysregulation, specifically Ybx2 hypermethylation, is a key driver of AKI-CKD transition.
  • Intervention targeting pericyte hypermethylation offers a promising strategy to halt AKI-CKD progression.
  • Demethylation therapy presents a potential therapeutic approach to improve long-term kidney outcomes after AKI.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
678
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
435
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
606
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
373
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
246
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
187